Cadila Healthcare Ltd
- All
- News
-
Zydus Cadila's US Firm Gets US Approval To Market Roflumilast Tablets
- Monday February 14, 2022
- World News | Press Trust of India
Cadlia Healthcare Ltd on Monday said group firm Zydus Pharmaceuticals (USA) Inc has received final approval from the US health regulator to market its generic version of Roflumilast tablets in the strength of 500 mcg indicated to reduce the risk of
-
www.ndtv.com
-
This Company Will Produce Pharma Firm Cadila's 3-Dose COVID-19 Vaccine 'ZyCov-D'
- Friday September 24, 2021
- India News | Reuters
Drugmaker Shilpa Medicare Limited said on Friday it had agreed to produce Cadila Healthcare Ltd's three-dose COVID-19 vaccine.
-
www.ndtv.com
-
Cadila Seeks Nod To Repurpose Hepatitis C Drug For Covid Treatment
- Monday April 5, 2021
- India News | Reuters
Cadila Healthcare Ltd has sought approval from local regulators to use a Hepatitis C drug as a treatment for COVID-19 following promising interim results from a late-stage trial, the drugmaker said on Monday.
-
www.ndtv.com
-
Phase 1 Trials Of 2 Covid Vaccines Reveal "Excellent Safety": Minister
- Tuesday September 15, 2020
- India News | Press Trust of India
Phase-I clinical trials have revealed "excellent safety" of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with ICMR and Cadila Healthcare Ltd and their immunogenicity testing is now in progress, Minister of State for Health Ashwini Choubey informed the Rajya Sabha on Tuesday.
-
www.ndtv.com
-
Zydus Cadila's US Firm Gets US Approval To Market Roflumilast Tablets
- Monday February 14, 2022
- World News | Press Trust of India
Cadlia Healthcare Ltd on Monday said group firm Zydus Pharmaceuticals (USA) Inc has received final approval from the US health regulator to market its generic version of Roflumilast tablets in the strength of 500 mcg indicated to reduce the risk of
-
www.ndtv.com
-
This Company Will Produce Pharma Firm Cadila's 3-Dose COVID-19 Vaccine 'ZyCov-D'
- Friday September 24, 2021
- India News | Reuters
Drugmaker Shilpa Medicare Limited said on Friday it had agreed to produce Cadila Healthcare Ltd's three-dose COVID-19 vaccine.
-
www.ndtv.com
-
Cadila Seeks Nod To Repurpose Hepatitis C Drug For Covid Treatment
- Monday April 5, 2021
- India News | Reuters
Cadila Healthcare Ltd has sought approval from local regulators to use a Hepatitis C drug as a treatment for COVID-19 following promising interim results from a late-stage trial, the drugmaker said on Monday.
-
www.ndtv.com
-
Phase 1 Trials Of 2 Covid Vaccines Reveal "Excellent Safety": Minister
- Tuesday September 15, 2020
- India News | Press Trust of India
Phase-I clinical trials have revealed "excellent safety" of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with ICMR and Cadila Healthcare Ltd and their immunogenicity testing is now in progress, Minister of State for Health Ashwini Choubey informed the Rajya Sabha on Tuesday.
-
www.ndtv.com